Type 2 Diabetes Market is Booming Worldwide with Key Players Eli Lilly and Co., Sanofi Aventis A/S, Novo Nordisk and More

 Srushti Helwande
  19th-Aug-2019
 29
XXF_1566204646_1.jpg Type 2 Diabetes Market

Type 2 diabetes (T2D) is a chronic disease that affects bodys blood sugar level. Elevated blood sugar level (hyperglycemia) causes detrimental effects on heart, kidneys, eyes, blood vessels, and nerves.

Type 2 Diabetes Market Leading Key Players:

The key players operating in the market include Eli Lilly and Co., Sanofi Aventis A/S, Novo Nordisk, Merck & Co., Inc., Chugai Pharmaceutical Co., Bristol-Myers Squibb, Pfizer Inc., Bayer AG, GlaxoSmithKline Plc., and AstraZeneca Plc.

Download Sample PDF Brochure at: https://www.alliedmarketresearch.com/request-toc-and-sample/3964

Type 2 Diabetes Market Driving Factor:

The major factor that drive the growth of the global type 2 diabetes (T2D) market are increase in prevalence of T2D disease globally. As per NCBI, 89 million cases of T2DM were recorded in 2014, and its prevalence is expected to reach to 330 million cases by 2022. Moreover, advancements in diabetic medications by pharmaceutical manufacturers fuel the market growth. Jardiance, a sodiumglucose cotransporter 2 inhibitor, and Tanzeum & Trulicity, two glucagon-like peptide-1 receptor agonists are the newest medications introduced in the market. However, lack of awareness among patients towards the availability of such medications restrains the market growth. Conversely, unmet medical needs in emerging economies are expected to provide lucrative growth opportunities for the market.

Type 2 Diabetes Market Segments:

The report segments the global type 2 diabetes market based on drug class, application, and geography. On the basis of drug class, the market is categorized into dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, thiazolidinediones, alpha-glucosidase inhibitors, sulfonylureas & other insulin secretagogues, biguanides, and sodiumglucose cotransporter 2 inhibitors. In terms of application, it is divided into glycemic control, cardiovascular safety, hypoglycemia avoidance, and others. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3964

Key Benefits

  • This report provides an extensive analysis of the current & emerging market trends and dynamics in the global type 2 diabetes market.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities across the geographies.
  • This report entails the detailed quantitative analysis of the current market and estimations from 2016 to 2023 to identify the prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
  • Region- and country-wise market conditions are comprehensively analyzed in the report.

Domain: Medical
Category: Biotech/Pharma
Contributing Organization:
Posted By: Srushti Helwande and Contact Srushti Helwande
SEMICONDUCTOR ANALYTICS

Recent Press Releases

The Implosive Nature of Schizophreni...

People who area unit schizophrenic area unit conventional as being straightforward to spot work the essential stereotype of somebody with compromised mental state. Get schizophren

15 September, 2019

Floor Gallery Offers A Wide Variety ...

Sunnyvale, CA (Sept 15, 2019) - Floor Gallery is an online flooring products store that offers a wide range of Flooring Store San Jose CA to customers, including Hardwood, Tile, Gl

15 September, 2019

Soundcloud Music Promotion With Assu...

15th September, 2019: Music lovers all over the globe are always craving for newer and newer genres of music tracks. Their appetite can be fulfilled only by professional music prom

15 September, 2019